142 related articles for article (PubMed ID: 25666966)
1. Tamoxifen and tranilast show a synergistic effect against breast cancer in vitro.
Darakhshan S; Ghanbari A; Gholami Rad F; Bidmeshki Pour A
Bratisl Lek Listy; 2015; 116(1):69-73. PubMed ID: 25666966
[TBL] [Abstract][Full Text] [Related]
2. Synergistic effects of tamoxifen and tranilast on VEGF and MMP-9 regulation in cultured human breast cancer cells.
Darakhshan S; Bidmeshkipour A; Khazaei M; Rabzia A; Ghanbari A
Asian Pac J Cancer Prev; 2013; 14(11):6869-74. PubMed ID: 24377619
[TBL] [Abstract][Full Text] [Related]
3. Tranilast enhances the anti-tumor effects of tamoxifen on human breast cancer cells in vitro.
Darakhshan S; Ghanbari A
J Biomed Sci; 2013 Oct; 20(1):76. PubMed ID: 24143895
[TBL] [Abstract][Full Text] [Related]
4. Rationale for sequential tamoxifen and anticancer drugs in adjuvant setting for patients with node- and receptor-positive breast cancer.
Kim R; Tanabe K; Emi M; Uchida Y; Osaki A; Toge T
Int J Oncol; 2005 Apr; 26(4):1025-31. PubMed ID: 15753998
[TBL] [Abstract][Full Text] [Related]
5. Synergistic anticancer effects of a bioactive subfraction of Strobilanthes crispus and tamoxifen on MCF-7 and MDA-MB-231 human breast cancer cell lines.
Yaacob NS; Kamal NN; Norazmi MN
BMC Complement Altern Med; 2014 Jul; 14():252. PubMed ID: 25034326
[TBL] [Abstract][Full Text] [Related]
6. Pterostilbene and tamoxifen show an additive effect against breast cancer in vitro.
Mannal P; McDonald D; McFadden D
Am J Surg; 2010 Nov; 200(5):577-80. PubMed ID: 21056131
[TBL] [Abstract][Full Text] [Related]
7. Inositol hexaphosphate (IP6) enhances the anti-proliferative effects of adriamycin and tamoxifen in breast cancer.
Tantivejkul K; Vucenik I; Eiseman J; Shamsuddin AM
Breast Cancer Res Treat; 2003 Jun; 79(3):301-12. PubMed ID: 12846414
[TBL] [Abstract][Full Text] [Related]
8. [The synergistic inhibitory effect of 5-aza-2-deoxycytidine and Tamoxifen on estrogen receptor alpha negative breast cancer cell lines in vitro].
Tang B; Peng ZH; Jiang J
Zhonghua Wai Ke Za Zhi; 2005 Dec; 43(23):1545-9. PubMed ID: 16412295
[TBL] [Abstract][Full Text] [Related]
9. [Arsenic trioxide restores ERα expression in ERα-negative human breast cancer cells and its treatment efficacy in combination with tamoxifen in xenografts in nude mice].
Zhang WJ; Xu DF; Fan QX; Wu XA; Wang F; Wang R; Wang LX
Zhonghua Zhong Liu Za Zhi; 2012 Sep; 34(9):645-51. PubMed ID: 23159075
[TBL] [Abstract][Full Text] [Related]
10. Effects of a combined treatment with mTOR inhibitor RAD001 and tamoxifen in vitro on growth and apoptosis of human cancer cells.
Treeck O; Wackwitz B; Haus U; Ortmann O
Gynecol Oncol; 2006 Aug; 102(2):292-9. PubMed ID: 16443261
[TBL] [Abstract][Full Text] [Related]
11. The Effects of Tamoxifen in Combination with Tranilast on CXCL12-CXCR4 Axis and Invasion in Breast Cancer Cell Lines.
Darakhshan S; Bidmeshkipour A; Mansouri K; Saeid HM; Ghanbari A
Iran J Pharm Res; 2014; 13(2):683-93. PubMed ID: 25237365
[TBL] [Abstract][Full Text] [Related]
12. Tranilast enhances the effect of anticancer agents in osteosarcoma.
Nakashima T; Nagano S; Setoguchi T; Sasaki H; Saitoh Y; Maeda S; Komiya S; Taniguchi N
Oncol Rep; 2019 Jul; 42(1):176-188. PubMed ID: 31059083
[TBL] [Abstract][Full Text] [Related]
13. Tamoxifen synergizes with 4-(E)-{(4-hydroxyphenylimino)-methylbenzene, 1,2-diol} and 4-(E)-{(p-tolylimino)-methylbenzene-1,2-diol}, novel azaresveratrol analogs, in inhibiting the proliferation of breast cancer cells.
Ronghe A; Chatterjee A; Bhat NK; Padhye S; Bhat HK
Oncotarget; 2016 Aug; 7(32):51747-51762. PubMed ID: 27351134
[TBL] [Abstract][Full Text] [Related]
14. Synergistic inhibitory effects of genistein and tamoxifen on human dysplastic and malignant epithelial breast cells in vitro.
Tanos V; Brzezinski A; Drize O; Strauss N; Peretz T
Eur J Obstet Gynecol Reprod Biol; 2002 May; 102(2):188-94. PubMed ID: 11950489
[TBL] [Abstract][Full Text] [Related]
15. A naringenin-tamoxifen combination impairs cell proliferation and survival of MCF-7 breast cancer cells.
Hatkevich T; Ramos J; Santos-Sanchez I; Patel YM
Exp Cell Res; 2014 Oct; 327(2):331-9. PubMed ID: 24881818
[TBL] [Abstract][Full Text] [Related]
16. Synergistic antitumor effects of a combination of interferon and tamoxifen on estrogen receptor-positive and receptor-negative human tumor cell lines in vivo and in vitro.
Lindner DJ; Borden EC
J Interferon Cytokine Res; 1997 Nov; 17(11):681-93. PubMed ID: 9402106
[TBL] [Abstract][Full Text] [Related]
17. Dual in vitro invasion/migration suppressing and tamoxifen response modulating effects of a recombinant anti-ALCAM scFv on breast cancer cells.
Darvishi B; Salehi M; Boroumandieh S; Majidzadeh-A K; Jalili N; Moradi-Kalbolandi S; Farahmand L
Cell Biochem Funct; 2020 Jul; 38(5):651-659. PubMed ID: 32196701
[TBL] [Abstract][Full Text] [Related]
18. Fatostatin in Combination with Tamoxifen Induces Synergistic Inhibition in ER-Positive Breast Cancer.
Liu Y; Zhang N; Zhang H; Wang L; Duan Y; Wang X; Chen T; Liang Y; Li Y; Song X; Li C; Han D; Chen B; Zhao W; Yang Q
Drug Des Devel Ther; 2020; 14():3535-3545. PubMed ID: 32921987
[TBL] [Abstract][Full Text] [Related]
19. Antitumor and anticancer stem cell activities of eribulin mesylate and antiestrogens in breast cancer cells.
Kurebayashi J; Kanomata N; Yamashita T; Shimo T; Moriya T
Breast Cancer; 2016 May; 23(3):425-36. PubMed ID: 25552385
[TBL] [Abstract][Full Text] [Related]
20. Effect of High-dose Vitamin C Combined With Anti-cancer Treatment on Breast Cancer Cells.
Lee SJ; Jeong JH; Lee IH; Lee J; Jung JH; Park HY; Lee DH; Chae YS
Anticancer Res; 2019 Feb; 39(2):751-758. PubMed ID: 30711954
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
